Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2022-12-23

MECHANISM OF ACTION OF POLYENE ANTIBIOTICS IN VITRO STUDIES FOR THE IMPROVEMENT OF THE THERAPEUTIC INDEX AGAINST LEISHMANIASIS

Objective


Leishmania are obligate intracellular parasites that cause a spectrum of diseases called leishmaniasis ranging from self healing skin ulcers to a fatal visceral infection. Only a few drugs are available for treatment of leishmaniasis and consequently, there is a need for new drugs. Among them the polyene antibiotic Amphotericin B (AmB) can be useful in the treatment of visceral and mucosal leishmaniasis, and is the most common drug for the treatment of fungal diseases.
This research project is to determine whether the liposomal formulations proposed for fungal diseases can be applied to leishmaniasis and, if so, whether they can be improved. AmB is generally assumed to act at the plasma membrane level of the parasite, by perturbing the membrane permeability. The study will determine the binding of AmB to plasma membranes of Leishmania in promastigote or amastigote form, or macrophages or tubular renal cells, and its consequences for the transmembrane permeability and the viability of the cells.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Programme(s)

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

UNIVERSITE PIERRE ET MARIE CURIE - PARIS VI
EU contribution
No data
Address
Place Jussieu 4
75252 PARIS
France
Total cost
No data

Participants (1)